ILMN · Transaction Feb 10, 2026 · Filed Mar 9, 2026 · $1,001 to $15,000
Illumina Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ILMN moving today?
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ILMN overview
Related filings and maps
Congress activity in ILMN
Illumina, Inc. - Common Stock · Transaction Feb 10, 2026 · Filed Mar 9, 2026 · $1,001 to $15,000
ILMN Common Stock · Transaction Jan 29, 2026 · Filed Feb 6, 2026 · Amount pending receipt enrichment
Illumina, Inc. - Common Stock · Transaction Oct 31, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Illumina, Inc. - Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
ILMN contract awards, year to date.
Public federal awards linked to this ticker.
ILMN lobbying filings, year to date.
Registered lobbying filings matched to Illumina Inc.